Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,349 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial.
McKetin R, Degan TJ, Saunders L, Nguyen L, Dore G, Shoptaw S, Farrell M, Degenhardt L, Kelly PJ, Turner A, Clare PJ, Dean OM, Arunogiri S, Colledge-Frisby S, Koeijers J, Goodman-Meza D, Sinclair B, Reid D, Hill H, Hayllar J, Christmass M, Cordaro F, Lundin R, Liaw W, Liu D, Holyoak E, Wu BT, Keygan J, Kontogiannis A, Palmer L, Morrison C, Wrobel A, Hyland B, Byrne M, Russell S, Zahra E, Berk M. McKetin R, et al. Among authors: byrne m. Trials. 2024 Jun 22;25(1):408. doi: 10.1186/s13063-024-08238-y. Trials. 2024. PMID: 38907288 Free PMC article.
Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study.
Larance B, Byrne M, Lintzeris N, Nielsen S, Grebely J, Degenhardt L, Shahbazi J, Shanahan M, Lancaster K, Dore G, Ali R, Farrell M; CoLAB study team. Larance B, et al. Among authors: byrne m. BMJ Open. 2020 Jul 31;10(7):e034389. doi: 10.1136/bmjopen-2019-034389. BMJ Open. 2020. PMID: 32737087 Free PMC article.
96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial.
Farrell M, Shahbazi J, Chambers M, Byrne M, Gholami J, Zahra E, Grebely J, Lintzeris N, Larance B, Ali R, Nielsen S, Dunlop A, Dore GJ, McDonough M, Montebello M, Weiss R, Rodgers C, Cook J, Degenhardt L; CoLAB study team. Farrell M, et al. Among authors: byrne m. Int J Drug Policy. 2024 May;127:104390. doi: 10.1016/j.drugpo.2024.104390. Epub 2024 Mar 23. Int J Drug Policy. 2024. PMID: 38522175 Free article.
Provider costs of treating opioid dependence with extended-release buprenorphine in Australia.
Settumba S, Shahbazi J, Byrne M, Degenhardt L, Grebely J, Larance B, Nielsen S, Lintzeris N, Ali R, Rodgers C, Blazey A, Weiss R, Dunlop A, McDonough M, Cook J, Farrell M. Settumba S, et al. Among authors: byrne m. Drug Alcohol Rev. 2025 Jan;44(1):179-194. doi: 10.1111/dar.13956. Epub 2024 Oct 6. Drug Alcohol Rev. 2025. PMID: 39370671 Free PMC article.
Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study.
Hajarizadeh B, Grebely J, Byrne M, Marks P, Amin J, McManus H, Butler T, Cunningham EB, Vickerman P, Martin NK, McHutchison JG, Brainard DM, Treloar C, Chambers GM, Grant L, Mcgrath C, Lloyd AR, Dore GJ; SToP-C study group. Hajarizadeh B, et al. Among authors: byrne m. Lancet Gastroenterol Hepatol. 2021 Jul;6(7):533-546. doi: 10.1016/S2468-1253(21)00077-7. Epub 2021 May 7. Lancet Gastroenterol Hepatol. 2021. PMID: 33965006
Incidence of hepatitis C virus infection in the prison setting: The SToP-C study.
Hajarizadeh B, Carson JM, Byrne M, Grebely J, Cunningham E, Amin J, Vickerman P, Martin NK, Treloar C, Martinello M, Lloyd AR, Dore GJ; SToP-C study group. Hajarizadeh B, et al. Among authors: byrne m. J Viral Hepat. 2024 Jan;31(1):21-34. doi: 10.1111/jvh.13895. Epub 2023 Nov 7. J Viral Hepat. 2024. PMID: 37936544 Free PMC article.
2,349 results